ETF innovation is truly staggering. After hosting ETF Prime for 7+ years and visiting weekly with the brightest minds the industry has to offer, I can only compare the sheer level of talent and entrepreneurial spirit to Silicon Valley. With so many unique and interesting ETF stories, I thought it would be fun to occasionally venture down the rabbit hole and delve deeper into areas I personally find fascinating.
This week, Brad Loncar, a Kansas City native and biotech investing expert, takes us into the world of China biotech. While Brad would never say this, I consider Brad among the smartest biotech investors I have ever met. Brad developed the indexes behind the Loncar Cancer Immunotherapy ETF (CNCR) and the recently launched China BioPharma ETF (CHNA). If you have any interest in biotech whatsoever, I think you’ll find this conversation insightful. Hope you enjoy!